Etusivu Diuretics and litholytic agents

Urokalun 225 mg, 100 tabl.

Basic

Ohjeet

Vaihtoehdot

Arvostelut

Tekniset tiedot

Valmistaja: Mitsubishi Tanabe Pharma Corporation

Aktiivinen ainesosa:

Säilyvyysaika: Usually 3 years (36 months) from the date of manufacture The exact date can be found on the packaging. Use only within the expiration date.

Nykyinen hinta

$28

Tee tilaus

Haluatko löytää useita vaihtoehtoja? Johtajamme selvittää kaikki tilauksesi yksityiskohdat ja valitsee sinulle sopivan toimitusvaihtoehdon.

Toimitus ja itsetoimitus

Varastointiolosuhteet

Store at temperatures up to 25°C - Keep out of direct sunlight and moisture - Store in original packaging - Keep out of reach of children

Urokalun

Overview:
Urokalun contains pipemidic acid, a quinolone derivative with antibacterial properties. It is used for the treatment and prevention of urinary tract infections (UTIs) and related conditions, including the prevention of urolithiasis-associated infections.

Indications for Use

Urinary Tract Infections (UTIs):

Acute and chronic infections, such as:

Cystitis (bladder infection).
Pyelonephritis (kidney infection).
Urethritis (urethral inflammation).

Prevention of Infections:

Prophylaxis during urological interventions to reduce the risk of infection.

Contraindications

Hypersensitivity:

Known allergy to pipemidic acid, quinolones, or any other components of the drug.

Severe Renal Insufficiency:

Contraindicated due to impaired drug clearance.

Pregnancy and Breastfeeding:

Use is contraindicated as safety during pregnancy and lactation has not been established.

Pediatric Use:

Not recommended for children or adolescents under 18 years of age.

Side Effects

Gastrointestinal System:

Nausea, vomiting, diarrhea.

Allergic Reactions:

Skin rash, pruritus (itching).

Nervous System:

Headache, dizziness.

Special Instructions

Patients with Liver Impairment:

Use cautiously under medical supervision; adjust dosage if necessary.

Long-Term Use:

Regular monitoring of renal and liver function is advised during prolonged treatment to prevent adverse effects.

Drug Interactions:

Avoid concurrent use with drugs that may affect kidney function or increase the risk of side effects. Inform your healthcare provider about all other medications being taken.

Consultation Required

Before starting Urokalun:

Consult a healthcare provider to evaluate the suitability of the treatment.
Dosage adjustments may be necessary based on your condition and renal function.

Avoid self-medication, as improper use of antibiotics can lead to resistance and other complications.

By following medical guidance, Urokalun can be effectively used to manage urinary tract conditions while minimizing risks.

Tablets for oral administration
- In this package: 225 mg tablets
- Other forms of release are also possible depending on the region (granules, capsules)